GradedHealth

Moderate drinking linked to lower type 2 diabetes risk — mainly in women

Pooling 55 cohort studies and 2.6 million people, researchers link moderate drinking to lower type 2 diabetes risk, mostly in women. Whisky trials hint at why.

Published October 2026

Short answer

Moderate drinking is linked to less type 2 diabetes in large cohort studies, clearest in women at about a drink a day. The evidence is limited and observational, men saw no benefit, and alcohol's other risks stay. Evidence grade C (Limited). Dose-response meta-analyses of 55 cohort studies; observational data cap the grade at B, and the benefit varies by sex and drink type, so it is downgraded to C.

Key takeaways

  • Across 55 cohort studies and 2.65 million people, women who drank moderately had up to 31% lower type 2 diabetes risk than lifetime abstainers [1].
  • The same analysis found no clear diabetes link in men [1].
  • An earlier analysis of 706,716 people found 17% lower risk for light drinkers and 26% for moderate drinkers [2].
  • Drink type matters: wine was linked to 15% lower risk, while spirits peaked at about 5% lower at 7–15 g of alcohol a day [3].
  • In a 17-day trial, 23 men drinking four whiskies daily raised adiponectin, a hormone tied to insulin sensitivity, by 11% [4].

What the study did

A 2023 dose-response meta-analysis in Diabetes Care pooled 55 cohort studies — 1,363,355 men and 1,290,628 women, with 147,957 cases of type 2 diabetes — and modelled how risk changed across daily alcohol intake, compared with lifetime abstainers [1]. Results were also split by sex and body mass index [1].

What it found

In women, the risk curve was J-shaped: it dipped to a maximum 31% lower risk (RR 0.69, 95% CI 0.64–0.74) at 16 g of alcohol a day — roughly two small (25 ml) measures of spirits — then rose again, with no benefit above 49 g a day. The lower risk appeared only in women who were overweight or obese. In men, no level of drinking was linked to a significant change [1].

That fits an earlier meta-analysis of 706,716 people, which found light and moderate drinkers had 17% and 26% lower risk than the lowest-intake group [2]. Drink type seems to matter: in a beverage-by-beverage analysis, wine was linked to a 15% lower risk, beer 4% and spirits 5%, with the spirits peak at only 7–15 g a day [3]. In Asian men, pooled cohorts found no benefit up to 57 g a day, and heavier intake raised risk [5].

How it fits

Small trials offer a plausible mechanism. In 23 middle-aged men, four glasses of whisky (40 g of alcohol) a day with dinner for 17 days raised adiponectin, a hormone linked to insulin sensitivity, by 11%; insulin sensitivity itself improved 21% in the subgroup who started out insulin-resistant [4]. In the same design, whisky raised the ability of blood to pull cholesterol out of cells by 17.5% [6], and a meta-analysis of 44 interventional studies found alcohol raises HDL cholesterol and adiponectin across wine, beer and spirits [7].

But marker improvements and disease outcomes don't always line up: genetic studies that use a gene variant predicting lower drinking have found no protection against heart disease [8], so part of the lower diabetes risk seen in cohorts may reflect other differences between drinkers and abstainers rather than the alcohol itself [1].

Limits

The evidence is observational: the studies followed people for years and cannot prove that alcohol caused the lower risk, and drinking was self-reported [1]. The benefit was mostly in women, did not appear in men, and was smaller for spirits than wine [1] [3]. None of this makes drinking a health strategy: moderate drinking has not been shown to extend life [9]. Alcohol is a Group 1 carcinogen, with no amount shown to be safe for cancer risk [10]; blood pressure rises with any type, including spirits [11]; drinking in pregnancy risks fetal alcohol spectrum disorder [12]. See Whisky and Spirits and Red Wine for the full picture.

Go deeper

  • Whisky and Spirits — Whisky and other spirits are drinks of almost pure alcohol, and the honest benefits are modest: small trials found whisky, gin and vodka raised 'good' choleste…
  • Red Wine — The famous link between red wine and a healthier heart comes from observational studies, and genetic studies that avoid their biases do not confirm it.

References

  1. The Relationship Between Alcohol Consumption, BMI, and Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis.. Diabetes Care, 2023.
  2. Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis.. Am J Clin Nutr, 2016.
  3. Specific types of alcoholic beverage consumption and risk of type 2 diabetes: A systematic review and meta-analysis.. J Diabetes Investig, 2017.
  4. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity.. Diabetes Care, 2004.
  5. The Dose-Response Relationship between Alcohol Consumption and the Risk of Type 2 Diabetes among Asian Men: A Systematic Review and Meta-Analysis of Prospective Cohort Studies.. J Diabetes Res, 2020.
  6. Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1.. J Lipid Res, 2004.
  7. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies.. BMJ, 2011.
  8. A burden of proof study on alcohol consumption and ischemic heart disease.. Nat Commun, 2024.
  9. Association Between Daily Alcohol Intake and Risk of All-Cause Mortality: A Systematic Review and Meta-analyses.. JAMA Netw Open, 2023.
  10. Cancer risk based on alcohol consumption levels: a comprehensive systematic review and meta-analysis.. Epidemiol Health, 2023.
  11. Type of Alcohol and Blood Pressure: The Copenhagen General Population Study.. Am J Med, 2024.
  12. Global Prevalence of Fetal Alcohol Spectrum Disorder Among Children and Youth: A Systematic Review and Meta-analysis.. JAMA Pediatr, 2017.